Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice

Osteoarthritis Cartilage. 2008 Jan;16(1):129-30. doi: 10.1016/j.joca.2007.08.001. Epub 2007 Sep 20.

Abstract

Objective: To determine the specificity and efficiency of the tamoxifen (TM)-induced Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.

Methods: Col2a1-CreER(T2) transgenic mice were bred with Rosa26 reporter mice. Two-week-old Col2a1-CreER(T2);R26R mice were administered TM for 5 days and were sacrificed 1 and 6 months after TM induction. X-Gal staining was performed.

Results: Efficient Cre-recombination is achieved in adult articular chondrocytes 1 and 6 months after TM induction.

Conclusion: Our findings demonstrate that the Col2a1-CreER(T2) transgenic mouse model is a valuable tool to target genes specifically expressed in articular chondrocytes in a temporally controlled manner in adult mice.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Bone Density Conservation Agents / pharmacology*
  • Cartilage, Articular / enzymology*
  • Cells, Cultured
  • Chondrocytes / enzymology*
  • Integrases / metabolism*
  • Mice
  • Mice, Transgenic
  • Polymerase Chain Reaction
  • Tamoxifen / pharmacology*

Substances

  • Bone Density Conservation Agents
  • Tamoxifen
  • Cre recombinase
  • Integrases